BioLife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, inc… Read more
BioLife Solutions Inc - Asset Resilience Ratio
BioLife Solutions Inc (BLFS) has an Asset Resilience Ratio of 29.61% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1994–2025)
This chart shows how BioLife Solutions Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down BioLife Solutions Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $120.18 Million | 29.61% |
| Total Liquid Assets | $120.18 Million | 29.61% |
Asset Resilience Insights
- Very High Liquidity: BioLife Solutions Inc maintains exceptional liquid asset reserves at 29.61% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
BioLife Solutions Inc Industry Peers by Asset Resilience Ratio
Compare BioLife Solutions Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
|
LKL International Bhd
KLSE:0182 |
Medical Instruments & Supplies | 0.38% |
Annual Asset Resilience Ratio for BioLife Solutions Inc (1994–2025)
The table below shows the annual Asset Resilience Ratio data for BioLife Solutions Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 13.77% | $55.89 Million | $405.88 Million | +11.47pp |
| 2024-12-31 | 2.30% | $9.20 Million | $399.49 Million | -1.64pp |
| 2023-12-31 | 3.95% | $16.29 Million | $412.71 Million | -5.66pp |
| 2022-12-31 | 9.61% | $43.26 Million | $450.23 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $552.60 Million | -- |
| 2020-12-31 | 2.50% | $5.87 Million | $234.83 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $12.14 Million | -- |
| 2016-12-31 | 20.83% | $1.65 Million | $7.93 Million | +7.48pp |
| 2015-12-31 | 13.35% | $1.65 Million | $12.37 Million | -32.69pp |
| 2014-12-31 | 46.04% | $7.40 Million | $16.07 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $3.35 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $3.17 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $1.66 Million | -- |
| 1996-12-31 | 1.82% | $110.15K | $6.04 Million | +0.63pp |
| 1995-12-31 | 1.19% | $100.31K | $8.40 Million | 0.00pp |
| 1994-12-31 | 1.19% | $100.31K | $8.40 Million | -- |